nodes	percent_of_prediction	percent_of_DWPC	metapath
Sucralfate—EGF—submandibular gland—pharynx cancer	0.222	0.387	CbGeAlD
Sucralfate—EGF—mouth—pharynx cancer	0.0302	0.0526	CbGeAlD
Sucralfate—FGA—brainstem—pharynx cancer	0.027	0.0471	CbGeAlD
Sucralfate—EGF—neck—pharynx cancer	0.0258	0.045	CbGeAlD
Sucralfate—PGA5—head—pharynx cancer	0.0257	0.0447	CbGeAlD
Sucralfate—FGB—lymphoid tissue—pharynx cancer	0.0216	0.0377	CbGeAlD
Sucralfate—EGF—parotid gland—pharynx cancer	0.021	0.0367	CbGeAlD
Sucralfate—EGF—saliva-secreting gland—pharynx cancer	0.0201	0.0351	CbGeAlD
Sucralfate—EGF—brainstem—pharynx cancer	0.0197	0.0344	CbGeAlD
Sucralfate—FGA—lymphoid tissue—pharynx cancer	0.0185	0.0323	CbGeAlD
Sucralfate—EGF—epithelium—pharynx cancer	0.0176	0.0306	CbGeAlD
Sucralfate—EGF—EGFR-dependent Endothelin signaling events—EGFR—pharynx cancer	0.0168	0.0393	CbGpPWpGaD
Sucralfate—FGG—lymph node—pharynx cancer	0.0158	0.0276	CbGeAlD
Sucralfate—EGF—trachea—pharynx cancer	0.0155	0.0271	CbGeAlD
Sucralfate—FGA—head—pharynx cancer	0.0149	0.026	CbGeAlD
Sucralfate—FGF2—trachea—pharynx cancer	0.0137	0.0239	CbGeAlD
Sucralfate—EGF—lymphoid tissue—pharynx cancer	0.0135	0.0236	CbGeAlD
Sucralfate—EGF—spinal cord—pharynx cancer	0.0123	0.0214	CbGeAlD
Sucralfate—EGF—ErbB receptor signaling network—EGFR—pharynx cancer	0.0111	0.0261	CbGpPWpGaD
Sucralfate—EGF—head—pharynx cancer	0.0109	0.019	CbGeAlD
Sucralfate—FGF2—spinal cord—pharynx cancer	0.0108	0.0189	CbGeAlD
Sucralfate—EGF—Bladder Cancer—CDH1—pharynx cancer	0.0107	0.025	CbGpPWpGaD
Sucralfate—FGB—Extracellular matrix organization—MMP8—pharynx cancer	0.01	0.0235	CbGpPWpGaD
Sucralfate—FGA—Extracellular matrix organization—MMP8—pharynx cancer	0.00981	0.023	CbGpPWpGaD
Sucralfate—FGG—Extracellular matrix organization—MMP8—pharynx cancer	0.00981	0.023	CbGpPWpGaD
Sucralfate—FGB—Integrin cell surface interactions—CDH1—pharynx cancer	0.00952	0.0223	CbGpPWpGaD
Sucralfate—FGA—Integrin cell surface interactions—CDH1—pharynx cancer	0.00933	0.0219	CbGpPWpGaD
Sucralfate—FGG—Integrin cell surface interactions—CDH1—pharynx cancer	0.00933	0.0219	CbGpPWpGaD
Sucralfate—EGF—Signaling by constitutively active EGFR—EGFR—pharynx cancer	0.00922	0.0216	CbGpPWpGaD
Sucralfate—EGF—GRB2 events in EGFR signaling—EGFR—pharynx cancer	0.00851	0.02	CbGpPWpGaD
Sucralfate—EGF—Stabilization and expansion of the E-cadherin adherens junction—CDH1—pharynx cancer	0.00836	0.0196	CbGpPWpGaD
Sucralfate—EGF—SHC1 events in EGFR signaling—EGFR—pharynx cancer	0.0082	0.0192	CbGpPWpGaD
Sucralfate—FGB—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—pharynx cancer	0.008	0.0188	CbGpPWpGaD
Sucralfate—EGF—Bladder Cancer—CCND1—pharynx cancer	0.00794	0.0186	CbGpPWpGaD
Sucralfate—EGF—a6b1 and a6b4 Integrin signaling—CDH1—pharynx cancer	0.00791	0.0186	CbGpPWpGaD
Sucralfate—FGA—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—pharynx cancer	0.00783	0.0184	CbGpPWpGaD
Sucralfate—FGG—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—pharynx cancer	0.00783	0.0184	CbGpPWpGaD
Sucralfate—EGF—lymph node—pharynx cancer	0.00763	0.0133	CbGeAlD
Sucralfate—EGF—Posttranslational regulation of adherens junction stability and dissassembly—CDH1—pharynx cancer	0.00751	0.0176	CbGpPWpGaD
Sucralfate—EGF—EGFR downregulation—EGFR—pharynx cancer	0.00717	0.0168	CbGpPWpGaD
Sucralfate—FGF2—lymph node—pharynx cancer	0.00673	0.0117	CbGeAlD
Sucralfate—EGF—GRB2 events in ERBB2 signaling—EGFR—pharynx cancer	0.0064	0.015	CbGpPWpGaD
Sucralfate—EGF—Bladder Cancer—EGFR—pharynx cancer	0.00623	0.0146	CbGpPWpGaD
Sucralfate—EGF—SHC1 events in ERBB2 signaling—EGFR—pharynx cancer	0.00608	0.0143	CbGpPWpGaD
Sucralfate—EGF—EGFR interacts with phospholipase C-gamma—EGFR—pharynx cancer	0.00566	0.0133	CbGpPWpGaD
Sucralfate—EGF—Arf6 signaling events—EGFR—pharynx cancer	0.00566	0.0133	CbGpPWpGaD
Sucralfate—EGF—PLCG1 events in ERBB2 signaling—EGFR—pharynx cancer	0.00553	0.013	CbGpPWpGaD
Sucralfate—EGF—Internalization of ErbB1—EGFR—pharynx cancer	0.0053	0.0124	CbGpPWpGaD
Sucralfate—EGF—Bladder Cancer—TP53—pharynx cancer	0.00523	0.0123	CbGpPWpGaD
Sucralfate—EGF—ErbB Signaling Pathway—CCND1—pharynx cancer	0.0051	0.012	CbGpPWpGaD
Sucralfate—EGF—Signaling events mediated by TCPTP—EGFR—pharynx cancer	0.00508	0.0119	CbGpPWpGaD
Sucralfate—EGF—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—pharynx cancer	0.00489	0.0115	CbGpPWpGaD
Sucralfate—EGF—Stabilization and expansion of the E-cadherin adherens junction—EGFR—pharynx cancer	0.00489	0.0115	CbGpPWpGaD
Sucralfate—EGF—a6b1 and a6b4 Integrin signaling—EGFR—pharynx cancer	0.00463	0.0108	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—CD79A—pharynx cancer	0.00439	0.0103	CbGpPWpGaD
Sucralfate—EGF—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—pharynx cancer	0.00439	0.0103	CbGpPWpGaD
Sucralfate—EGF—Regulation of Telomerase—CCND1—pharynx cancer	0.00424	0.00994	CbGpPWpGaD
Sucralfate—EGF—Signaling events mediated by PTP1B—EGFR—pharynx cancer	0.00412	0.00966	CbGpPWpGaD
Sucralfate—EGF—ErbB Signaling Pathway—EGFR—pharynx cancer	0.004	0.00938	CbGpPWpGaD
Sucralfate—EGF—Thromboxane A2 receptor signaling—EGFR—pharynx cancer	0.00388	0.00911	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—MMP8—pharynx cancer	0.00387	0.00909	CbGpPWpGaD
Sucralfate—FGG—Glucocorticoid receptor regulatory network—TP53—pharynx cancer	0.00385	0.00903	CbGpPWpGaD
Sucralfate—EGF—SHP2 signaling—EGFR—pharynx cancer	0.00378	0.00886	CbGpPWpGaD
Sucralfate—EGF—ErbB Signaling Pathway—TP53—pharynx cancer	0.00336	0.00787	CbGpPWpGaD
Sucralfate—EGF—Regulation of Telomerase—EGFR—pharynx cancer	0.00332	0.0078	CbGpPWpGaD
Sucralfate—FGB—Extracellular matrix organization—CDH1—pharynx cancer	0.00314	0.00737	CbGpPWpGaD
Sucralfate—FGA—Extracellular matrix organization—CDH1—pharynx cancer	0.00308	0.00722	CbGpPWpGaD
Sucralfate—FGG—Extracellular matrix organization—CDH1—pharynx cancer	0.00308	0.00722	CbGpPWpGaD
Sucralfate—FGA—Disease—B4GALT5—pharynx cancer	0.0029	0.0068	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—CD79A—pharynx cancer	0.00278	0.00652	CbGpPWpGaD
Sucralfate—EGF—Constitutive PI3K/AKT Signaling in Cancer—EGFR—pharynx cancer	0.00276	0.00646	CbGpPWpGaD
Sucralfate—ALB—lymph node—pharynx cancer	0.00264	0.0046	CbGeAlD
Sucralfate—FGF2—Neural Crest Differentiation—CDH1—pharynx cancer	0.00262	0.00615	CbGpPWpGaD
Sucralfate—EGF—PI-3K cascade—EGFR—pharynx cancer	0.00248	0.00582	CbGpPWpGaD
Sucralfate—EGF—PI3K/AKT activation—EGFR—pharynx cancer	0.00242	0.00568	CbGpPWpGaD
Sucralfate—EGF—GAB1 signalosome—EGFR—pharynx cancer	0.0024	0.00564	CbGpPWpGaD
Sucralfate—EGF—ErbB1 downstream signaling—EGFR—pharynx cancer	0.00235	0.00551	CbGpPWpGaD
Sucralfate—EGF—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—pharynx cancer	0.00235	0.00551	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—CCND1—pharynx cancer	0.00186	0.00437	CbGpPWpGaD
Sucralfate—EGF—Signaling by SCF-KIT—EGFR—pharynx cancer	0.00186	0.00435	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00186	0.00435	CbGpPWpGaD
Sucralfate—EGF—Disease—B4GALT5—pharynx cancer	0.00181	0.00425	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.00178	0.00416	CbGpPWpGaD
Sucralfate—EGF—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	0.00178	0.00416	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CD79A—pharynx cancer	0.00177	0.00415	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB4—EGFR—pharynx cancer	0.00175	0.0041	CbGpPWpGaD
Sucralfate—FGF2—Constitutive PI3K/AKT Signaling in Cancer—EGFR—pharynx cancer	0.00174	0.00409	CbGpPWpGaD
Sucralfate—EGF—Downstream signal transduction—EGFR—pharynx cancer	0.00167	0.00391	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR—EGFR—pharynx cancer	0.00166	0.00389	CbGpPWpGaD
Sucralfate—EGF—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.00166	0.00389	CbGpPWpGaD
Sucralfate—EGF—Signaling by ERBB2—EGFR—pharynx cancer	0.00165	0.00387	CbGpPWpGaD
Sucralfate—EGF—DAP12 signaling—EGFR—pharynx cancer	0.00164	0.00386	CbGpPWpGaD
Sucralfate—EGF—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.00162	0.0038	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00161	0.00378	CbGpPWpGaD
Sucralfate—FGF2—PI-3K cascade—EGFR—pharynx cancer	0.00157	0.00368	CbGpPWpGaD
Sucralfate—EGF—DAP12 interactions—EGFR—pharynx cancer	0.00155	0.00363	CbGpPWpGaD
Sucralfate—EGF—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.00155	0.00363	CbGpPWpGaD
Sucralfate—EGF—Signaling by FGFR in disease—EGFR—pharynx cancer	0.00155	0.00363	CbGpPWpGaD
Sucralfate—FGF2—PI3K/AKT activation—EGFR—pharynx cancer	0.00153	0.0036	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR—EGFR—pharynx cancer	0.00153	0.00359	CbGpPWpGaD
Sucralfate—FGF2—GAB1 signalosome—EGFR—pharynx cancer	0.00152	0.00357	CbGpPWpGaD
Sucralfate—EGF—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.00152	0.00356	CbGpPWpGaD
Sucralfate—EGF—Signaling by PDGF—EGFR—pharynx cancer	0.00151	0.00355	CbGpPWpGaD
Sucralfate—FGF2—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—pharynx cancer	0.00149	0.00349	CbGpPWpGaD
Sucralfate—EGF—Focal Adhesion—EGFR—pharynx cancer	0.00146	0.00343	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00146	0.00341	CbGpPWpGaD
Sucralfate—EGF—B Cell Activation—EGFR—pharynx cancer	0.00143	0.00336	CbGpPWpGaD
Sucralfate—EGF—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.00137	0.00321	CbGpPWpGaD
Sucralfate—EGF—MAPK Signaling Pathway—TP53—pharynx cancer	0.00135	0.00318	CbGpPWpGaD
Sucralfate—EGF—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00122	0.00287	CbGpPWpGaD
Sucralfate—FGF2—Extracellular matrix organization—CDH1—pharynx cancer	0.00122	0.00285	CbGpPWpGaD
Sucralfate—FGF2—Signaling by SCF-KIT—EGFR—pharynx cancer	0.00117	0.00275	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00117	0.00275	CbGpPWpGaD
Sucralfate—FGF2—Disease—B4GALT5—pharynx cancer	0.00115	0.00269	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.00112	0.00263	CbGpPWpGaD
Sucralfate—FGF2—Regulation of Actin Cytoskeleton—EGFR—pharynx cancer	0.00112	0.00263	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CD79A—pharynx cancer	0.00112	0.00263	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB4—EGFR—pharynx cancer	0.00111	0.00259	CbGpPWpGaD
Sucralfate—EGF—Immune System—CD79A—pharynx cancer	0.00107	0.00252	CbGpPWpGaD
Sucralfate—FGF2—Downstream signal transduction—EGFR—pharynx cancer	0.00106	0.00248	CbGpPWpGaD
Sucralfate—EGF—Signaling by NGF—EGFR—pharynx cancer	0.00105	0.00247	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR—EGFR—pharynx cancer	0.00105	0.00246	CbGpPWpGaD
Sucralfate—FGF2—Signaling by ERBB2—EGFR—pharynx cancer	0.00105	0.00245	CbGpPWpGaD
Sucralfate—FGF2—DAP12 signaling—EGFR—pharynx cancer	0.00104	0.00244	CbGpPWpGaD
Sucralfate—FGF2—Downstream signaling events of B Cell Receptor (BCR)—EGFR—pharynx cancer	0.00103	0.0024	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—CDH1—pharynx cancer	0.000987	0.00231	CbGpPWpGaD
Sucralfate—FGF2—Fc epsilon receptor (FCERI) signaling—EGFR—pharynx cancer	0.000979	0.0023	CbGpPWpGaD
Sucralfate—FGF2—Signaling by FGFR in disease—EGFR—pharynx cancer	0.000979	0.0023	CbGpPWpGaD
Sucralfate—FGF2—DAP12 interactions—EGFR—pharynx cancer	0.000979	0.0023	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR—EGFR—pharynx cancer	0.00097	0.00228	CbGpPWpGaD
Sucralfate—FGF2—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.000962	0.00225	CbGpPWpGaD
Sucralfate—FGF2—Signaling by PDGF—EGFR—pharynx cancer	0.000957	0.00224	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.000921	0.00216	CbGpPWpGaD
Sucralfate—FGB—Hemostasis—TP53—pharynx cancer	0.000917	0.00215	CbGpPWpGaD
Sucralfate—FGF2—B Cell Activation—EGFR—pharynx cancer	0.000906	0.00212	CbGpPWpGaD
Sucralfate—FGG—Hemostasis—TP53—pharynx cancer	0.000898	0.00211	CbGpPWpGaD
Sucralfate—FGA—Hemostasis—TP53—pharynx cancer	0.000898	0.00211	CbGpPWpGaD
Sucralfate—FGF2—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.000867	0.00203	CbGpPWpGaD
Sucralfate—FGF2—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.000773	0.00181	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CD79A—pharynx cancer	0.00068	0.00159	CbGpPWpGaD
Sucralfate—FGF2—Signaling by NGF—EGFR—pharynx cancer	0.000667	0.00156	CbGpPWpGaD
Sucralfate—ALB—Folate Metabolism—TP53—pharynx cancer	0.00066	0.00155	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—CDH1—pharynx cancer	0.000625	0.00146	CbGpPWpGaD
Sucralfate—EGF—Innate Immune System—EGFR—pharynx cancer	0.000601	0.00141	CbGpPWpGaD
Sucralfate—EGF—Immune System—CDH1—pharynx cancer	0.000599	0.0014	CbGpPWpGaD
Sucralfate—EGF—Adaptive Immune System—EGFR—pharynx cancer	0.000577	0.00135	CbGpPWpGaD
Sucralfate—EGF—Hemostasis—TP53—pharynx cancer	0.00056	0.00131	CbGpPWpGaD
Sucralfate—FGA—Disease—EGFR—pharynx cancer	0.000518	0.00121	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—CCND1—pharynx cancer	0.000472	0.00111	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—CCND1—pharynx cancer	0.000462	0.00108	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—CCND1—pharynx cancer	0.000462	0.00108	CbGpPWpGaD
Sucralfate—ALB—Metabolism—CNDP2—pharynx cancer	0.000462	0.00108	CbGpPWpGaD
Sucralfate—FGF2—Developmental Biology—EGFR—pharynx cancer	0.000431	0.00101	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ADH7—pharynx cancer	0.000418	0.000979	CbGpPWpGaD
Sucralfate—FGF2—Innate Immune System—EGFR—pharynx cancer	0.00038	0.000892	CbGpPWpGaD
Sucralfate—FGF2—Immune System—CDH1—pharynx cancer	0.000379	0.000888	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—EGFR—pharynx cancer	0.00037	0.000868	CbGpPWpGaD
Sucralfate—ALB—Metabolism—ADH1B—pharynx cancer	0.000366	0.000859	CbGpPWpGaD
Sucralfate—FGF2—Adaptive Immune System—EGFR—pharynx cancer	0.000365	0.000856	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—EGFR—pharynx cancer	0.000363	0.00085	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—EGFR—pharynx cancer	0.000363	0.00085	CbGpPWpGaD
Sucralfate—EGF—Immune System—EGFR—pharynx cancer	0.00035	0.000821	CbGpPWpGaD
Sucralfate—ALB—Metabolism—B4GALT5—pharynx cancer	0.00035	0.000821	CbGpPWpGaD
Sucralfate—EGF—Disease—EGFR—pharynx cancer	0.000323	0.000758	CbGpPWpGaD
Sucralfate—FGB—Signaling Pathways—TP53—pharynx cancer	0.000311	0.000729	CbGpPWpGaD
Sucralfate—FGG—Signaling Pathways—TP53—pharynx cancer	0.000304	0.000714	CbGpPWpGaD
Sucralfate—FGA—Signaling Pathways—TP53—pharynx cancer	0.000304	0.000714	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—CCND1—pharynx cancer	0.000288	0.000676	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—EGFR—pharynx cancer	0.000226	0.000531	CbGpPWpGaD
Sucralfate—FGF2—Immune System—EGFR—pharynx cancer	0.000222	0.000519	CbGpPWpGaD
Sucralfate—FGF2—Disease—EGFR—pharynx cancer	0.000205	0.00048	CbGpPWpGaD
Sucralfate—EGF—Signaling Pathways—TP53—pharynx cancer	0.00019	0.000446	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—CCND1—pharynx cancer	0.000183	0.000428	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—EGFR—pharynx cancer	0.000143	0.000336	CbGpPWpGaD
Sucralfate—ALB—Hemostasis—TP53—pharynx cancer	0.000129	0.000303	CbGpPWpGaD
Sucralfate—FGF2—Signaling Pathways—TP53—pharynx cancer	0.00012	0.000282	CbGpPWpGaD
